Kanabo Group Plc (LON:KNB)
London · Delayed Price · Currency is GBP · Price in GBX 0.2200
-0.0050 (-2.22%)
At close: May 19, 2026
Kanabo Group Market Cap
Kanabo Group has a market cap or net worth of 1.39 million as of October 9, 2026. It is the 48,231st most valuable company in the world and the 1,099th biggest in the United Kingdom. Its market cap has decreased by 2.22% in one year.
Market Cap
1.39M
Enterprise Value
n/a
Revenue
1.14M
Global Rank
Country Rank
#1,099 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 17, 2021, Kanabo Group's market cap has decreased from 146.97M to 1.39M, a decrease of -99.05%. That is a compound annual growth rate of -58.82%.
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.39M | -74.12% |
| Dec 31, 2024 | 5.38M | -69.64% |
| Dec 29, 2023 | 17.71M | 120.37% |
| Dec 30, 2022 | 8.04M | -84.49% |
| Dec 31, 2021 | 51.80M | -64.76% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.47B |
| GSK plc | 70.48B |
| Haleon | 29.14B |
| Smith & Nephew | 8.51B |
| Imaging Biometrics | 2.41M |
| Physiomics | 2.38M |
| BSF Enterprise | 2.16M |
| ValiRx | 1.78M |